(3-IMIDAZOL-1-YL-PROPYL)-(5-METHYL-THIOPHEN-2-YLMETHYL)-AMINE
![]() |
- $200 - $772.7
- Product name: (3-IMIDAZOL-1-YL-PROPYL)-(5-METHYL-THIOPHEN-2-YLMETHYL)-AMINE
- CAS: 799262-41-2
- MF: C12H17N3S
- MW: 235.35
- EINECS:
- MDL Number:MFCD05237812
- Synonyms:(3-IMIDAZOL-1-YL-PROPYL)-(5-METHYL-THIOPHEN-2-YLMETHYL)-AMINE;1H-Imidazole-1-propanamine, N-[(5-methyl-2-thienyl)methyl]-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0080949
- Product description(3-IMIDAZOL-1-YL-PROPYL)-(5-METHYL-THIOPHEN-2-YLMETHYL)-AMINE 95.00%
- Packaging500MG
- Price$772.7
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012309
- Product description(3-Imidazol-1-yl-propyl)-(5-methyl-thiophen-2-ylmethyl)-amine
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number012309
- Product description(3-Imidazol-1-yl-propyl)-(5-methyl-thiophen-2-ylmethyl)-amine
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0080949 | (3-IMIDAZOL-1-YL-PROPYL)-(5-METHYL-THIOPHEN-2-YLMETHYL)-AMINE 95.00% | 500MG | $772.7 | 2021-12-16 | Buy |
Matrix Scientific | 012309 | (3-Imidazol-1-yl-propyl)-(5-methyl-thiophen-2-ylmethyl)-amine | 500mg | $200 | 2021-12-16 | Buy |
Matrix Scientific | 012309 | (3-Imidazol-1-yl-propyl)-(5-methyl-thiophen-2-ylmethyl)-amine | 1g | $308 | 2021-12-16 | Buy |
Properties
Boiling point :414.2±40.0 °C(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :8.45±0.19(Predicted)
Density :1.16±0.1 g/cm3(Predicted)
pka :8.45±0.19(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||
Precautionary statements: |
|